N

Novocure

Home/ Companies/ Novocure

About

Novocure is a commercial-stage oncology company focused on developing and commercializing Tumor Treating Fields (TTFields) therapy. This therapy uses electric fields to disrupt cancer cell division. Novocure is headquartered in St. Helier, Jersey.

Novocure’s TTFields therapy is regulated as a medical device. In the United States, the system is FDA-approved for the treatment of glioblastoma and mesothelioma. In the European Union, the device is CE-marked under the Medical Device Regulation (MDR 2017/745).

Company Details

Markets

Rest of World

Is This Your Company?

Claim this listing to update your profile, add your logo, and manage your information.

Claim This Listing
Scroll to Top